LFWD
Lifeward Ltd. (NASDAQ)
Healthcare — Medical Devices
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.
Price History
Fundamentals
| Market Cap | $21.64M |
| P/E Ratio (TTM) | - |
| Forward P/E | -4.32 |
| EPS (TTM) | $-18.33 |
| Dividend Yield | - |
| Profit Margin | -123.66% |
| Revenue Growth | -22.10% |
| ROE | -209.10% |
| Debt/Equity | 140.11 |
| Recommendation | None |
| Analyst Target | $20.00 |
| Analysts | 2 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 65.0 |
| Beta | 0.37 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $10.98 |
| 52-Week Low | $4.14 |
| 50-Day Avg | $7.08 |
| 200-Day Avg | $7.27 |
| Avg Volume | 8.8K |
| Volume | 8.3K |
Performance Analysis
NEUTRALLFWD presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:18 UTC
Back to Screener Export Report